-
1
-
-
36349025232
-
Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?
-
Girinsky T., Ghalibafian M., Bonniaud G., et al. Is FDG-PET scan in patients with early stage Hodgkin lymphoma of any value in the implementation of the involved-node radiotherapy concept and dose painting?. Radiother Oncol (2007)
-
(2007)
Radiother Oncol
-
-
Girinsky, T.1
Ghalibafian, M.2
Bonniaud, G.3
-
2
-
-
33947496614
-
Revised response criteria for malignant lymphoma
-
Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 (2007) 579-586
-
(2007)
J Clin Oncol
, vol.25
, pp. 579-586
-
-
Cheson, B.D.1
Pfistner, B.2
Juweid, M.E.3
-
3
-
-
21044443290
-
Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT)
-
Yahalom J. Transformation in the use of radiation therapy of Hodgkin lymphoma: new concepts and indications lead to modern field design and are assisted by PET imaging and intensity modulated radiation therapy (IMRT). Eur J Haematol 75 (2005) 90-97
-
(2005)
Eur J Haematol
, vol.75
, pp. 90-97
-
-
Yahalom, J.1
-
4
-
-
4344699405
-
ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results
-
Bonadonna G., Bonfante V., Viviani S., Di Russo A., Villani F., and Valagussa P. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results. J Clin Oncol 22 (2004) 2835-2841
-
(2004)
J Clin Oncol
, vol.22
, pp. 2835-2841
-
-
Bonadonna, G.1
Bonfante, V.2
Viviani, S.3
Di Russo, A.4
Villani, F.5
Valagussa, P.6
-
5
-
-
0141939066
-
Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group
-
Engert A., Schiller P., Josting A., et al. Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with early-stage unfavorable Hodgkin's lymphoma: results of the HD8 trial of the German Hodgkin's Lymphoma Study Group. J Clin Oncol 21 (2003) 3601-3608
-
(2003)
J Clin Oncol
, vol.21
, pp. 3601-3608
-
-
Engert, A.1
Schiller, P.2
Josting, A.3
-
6
-
-
4243633257
-
MOPP/ABV hybrid and irradiation in unfavorable supradiaphragmatic clinical stages I-II Hodgkin's disease: comparison of three treatment modalities. Preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients
-
Ferme C., Eghbali H., Hagenbeek A., et al. MOPP/ABV hybrid and irradiation in unfavorable supradiaphragmatic clinical stages I-II Hodgkin's disease: comparison of three treatment modalities. Preliminary results of the EORTC-GELA H8-U randomized trial in 995 patients. Blood 96 (2000) 576A
-
(2000)
Blood
, vol.96
-
-
Ferme, C.1
Eghbali, H.2
Hagenbeek, A.3
-
7
-
-
33746868428
-
Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F trial
-
Eghbali H., Brice P., Creemers G.-Y., et al. Comparison of three radiation dose levels after EBVP regimen in favorable supradiaphragmatic clinical stages (CS) I-II Hodgkin's lymphoma (HL): preliminary results of the EORTC-GELA H9-F trial. Blood 106 (2005) 240A
-
(2005)
Blood
, vol.106
-
-
Eghbali, H.1
Brice, P.2
Creemers, G.-Y.3
-
8
-
-
23044452477
-
Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group
-
Meyer R.M., Gospodarowicz M.K., Connors J.M., et al. Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group. J Clin Oncol 23 (2005) 4634-4642
-
(2005)
J Clin Oncol
, vol.23
, pp. 4634-4642
-
-
Meyer, R.M.1
Gospodarowicz, M.K.2
Connors, J.M.3
-
9
-
-
0037106383
-
Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy
-
Nachman J.B., Sposto R., Herzog P., et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20 (2002) 3765-3771
-
(2002)
J Clin Oncol
, vol.20
, pp. 3765-3771
-
-
Nachman, J.B.1
Sposto, R.2
Herzog, P.3
-
10
-
-
33845354279
-
Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials
-
Franklin J., Pluetschow A., Paus M., et al. Second malignancy risk associated with treatment of Hodgkin's lymphoma: meta-analysis of the randomised trials. Ann Oncol 17 (2006) 1749-1760
-
(2006)
Ann Oncol
, vol.17
, pp. 1749-1760
-
-
Franklin, J.1
Pluetschow, A.2
Paus, M.3
-
11
-
-
36348941080
-
Very long-term follow-up of the Danish National Hodgkin Study Group's randomized trial of radiotherapy (RT) alone vs. combined modality treatment (CMT) for early stage Hodgkin lymphoma, with special reference to second tumours and overall survival
-
Specht L. Very long-term follow-up of the Danish National Hodgkin Study Group's randomized trial of radiotherapy (RT) alone vs. combined modality treatment (CMT) for early stage Hodgkin lymphoma, with special reference to second tumours and overall survival. Blood 102 (2003) 637A
-
(2003)
Blood
, vol.102
-
-
Specht, L.1
-
12
-
-
31144445165
-
Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease
-
Shahidi M., Kamangari N., Ashley S., Cunningham D., and Horwich A. Site of relapse after chemotherapy alone for stage I and II Hodgkin's disease. Radiother Oncol 78 (2006) 1-5
-
(2006)
Radiother Oncol
, vol.78
, pp. 1-5
-
-
Shahidi, M.1
Kamangari, N.2
Ashley, S.3
Cunningham, D.4
Horwich, A.5
-
13
-
-
33746346422
-
Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines
-
Girinsky T., van der Maazen R., Specht L., et al. Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79 (2006) 270-277
-
(2006)
Radiother Oncol
, vol.79
, pp. 270-277
-
-
Girinsky, T.1
van der Maazen, R.2
Specht, L.3
-
14
-
-
34250698039
-
2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas
-
Specht L. 2-[18F]fluoro-2-deoxyglucose positron-emission tomography in staging, response evaluation, and treatment planning of lymphomas. Semin Radiat Oncol 17 (2007) 190-197
-
(2007)
Semin Radiat Oncol
, vol.17
, pp. 190-197
-
-
Specht, L.1
-
15
-
-
33846965941
-
Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma
-
Hutchings M., Loft A., Hansen M., Berthelsen A.K., and Specht L. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma. Eur J Haematol 78 (2007) 206-212
-
(2007)
Eur J Haematol
, vol.78
, pp. 206-212
-
-
Hutchings, M.1
Loft, A.2
Hansen, M.3
Berthelsen, A.K.4
Specht, L.5
-
16
-
-
33645963756
-
Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma
-
Hutchings M., Loft A., Hansen M., et al. Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 91 (2006) 482-489
-
(2006)
Haematologica
, vol.91
, pp. 482-489
-
-
Hutchings, M.1
Loft, A.2
Hansen, M.3
-
17
-
-
0035074636
-
Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease
-
Jerusalem G., Beguin Y., Fassotte M.F., et al. Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 86 (2001) 266-273
-
(2001)
Haematologica
, vol.86
, pp. 266-273
-
-
Jerusalem, G.1
Beguin, Y.2
Fassotte, M.F.3
-
18
-
-
0036405370
-
Positron emission tomography for the staging of Hodgkin's lymphoma - increasing the body of evidence in favor of the method
-
Menzel C., Dobert N., Mitrou P., et al. Positron emission tomography for the staging of Hodgkin's lymphoma - increasing the body of evidence in favor of the method. Acta Oncol 41 (2002) 430-436
-
(2002)
Acta Oncol
, vol.41
, pp. 430-436
-
-
Menzel, C.1
Dobert, N.2
Mitrou, P.3
-
19
-
-
0036124658
-
Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma
-
Wirth A., Seymour J.F., Hicks R.J., et al. Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma. Am J Med 112 (2002) 262-268
-
(2002)
Am J Med
, vol.112
, pp. 262-268
-
-
Wirth, A.1
Seymour, J.F.2
Hicks, R.J.3
|